Suppr超能文献

解析间皮素-黏蛋白 16/CA125 相互作用的结构。

Structural elucidation of the mesothelin-mucin-16/CA125 interaction.

机构信息

Division of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Division of Basic Science, Fred Hutchinson Cancer Center, Seattle, WA, USA.

出版信息

Structure. 2024 Aug 8;32(8):1049-1054.e2. doi: 10.1016/j.str.2024.04.011. Epub 2024 May 3.

Abstract

Mesothelin (MSLN) is a cell-surface glycoprotein expressed at low levels on normal mesothelium but overexpressed in many cancers. Mesothelin has been implicated to play role/s in cell adhesion and multiple signaling pathways. Mucin-16/CA125 is an enormous cell-surface glycoprotein, also normally expressed on mesothelium and implicated in the progression and metastasis of several cancers, and directly binds mesothelin. However, the precise biological function/s of mesothelin and mucin-16/CA125 remain mysterious. We report protein engineering and recombinant production, qualitative and quantitative binding studies, and a crystal structure determination elucidating the molecular-level details governing recognition of mesothelin by mucin-16/CA125. The interface is small, consistent with the ∼micromolar binding constant and is free of glycan-mediated interactions. Sequence comparisons and modeling suggest that multiple mucin-16/CA125 modules can interact with mesothelin through comparable interactions, potentially generating a high degree of avidity at the cell surface to overcome the weak affinity, with implications for functioning and therapeutic interventions.

摘要

间皮素 (MSLN) 是一种细胞表面糖蛋白,在正常间皮细胞中低表达,但在许多癌症中过度表达。间皮素被认为在细胞黏附和多种信号通路中发挥作用。黏蛋白-16/CA125 是一种巨大的细胞表面糖蛋白,也在间皮细胞中正常表达,并参与多种癌症的进展和转移,并且直接与间皮素结合。然而,间皮素和黏蛋白-16/CA125 的确切生物学功能仍然神秘。我们报告了蛋白质工程和重组生产、定性和定量结合研究以及晶体结构测定,阐明了控制黏蛋白-16/CA125 识别间皮素的分子水平细节。界面很小,与 ∼ 微摩尔的结合常数一致,并且没有糖介导的相互作用。序列比较和建模表明,多个黏蛋白-16/CA125 模块可以通过类似的相互作用与间皮素相互作用,可能在细胞表面产生高亲和力,以克服弱亲和力,这对功能和治疗干预具有重要意义。

相似文献

1
Structural elucidation of the mesothelin-mucin-16/CA125 interaction.
Structure. 2024 Aug 8;32(8):1049-1054.e2. doi: 10.1016/j.str.2024.04.011. Epub 2024 May 3.
3
Mesothelin-targeted CAR-T therapy combined with irinotecan for the treatment of solid cancer.
J Cancer Res Clin Oncol. 2023 Nov;149(16):15027-15038. doi: 10.1007/s00432-023-05279-9. Epub 2023 Aug 23.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Biology of Mesothelin and Clinical Implications: A Review of Existing Literature.
World J Oncol. 2023 Oct;14(5):340-349. doi: 10.14740/wjon1655. Epub 2023 Sep 20.
2
Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies.
Cancer Res Commun. 2023 Feb 1;3(2):175-191. doi: 10.1158/2767-9764.CRC-22-0306. eCollection 2023 Feb.
3
Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
Proteins. 2022 May;90(5):1210-1218. doi: 10.1002/prot.26303. Epub 2022 Jan 25.
4
Highly accurate protein structure prediction with AlphaFold.
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
5
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20.
6
ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery.
Front Immunol. 2021 Apr 23;12:658372. doi: 10.3389/fimmu.2021.658372. eCollection 2021.
7
Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer.
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188503. doi: 10.1016/j.bbcan.2021.188503. Epub 2021 Jan 7.
8
MolProbity: More and better reference data for improved all-atom structure validation.
Protein Sci. 2018 Jan;27(1):293-315. doi: 10.1002/pro.3330. Epub 2017 Nov 27.
9
Polder maps: improving OMIT maps by excluding bulk solvent.
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):148-157. doi: 10.1107/S2059798316018210.
10
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer.
J Innate Immun. 2017;9(3):281-299. doi: 10.1159/000453594. Epub 2017 Jan 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验